Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer
Background: Patients with locally advanced rectal cancer are treated with preoperative chemoradiotherapy followed by surgical resection. Despite similar clinical parameters (uT2-3, uN+) and standard therapy, patients’ prognoses differ widely. A possible prediction of prognosis through microRNAs as b...
Main Authors: | Azadeh Azizian, Ingo Epping, Frank Kramer, Peter Jo, Markus Bernhardt, Julia Kitz, Gabriela Salinas, Hendrik A. Wolff, Marian Grade, Tim Beißbarth, B. Michael Ghadimi, Jochen Gaedcke |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/17/4/568 |
Similar Items
-
Role of adjuvant chemotherapy in patients with rectal cancer after preoperative chemoradiotherapy: results of a retrospective study
by: M. Yu. Fedyanin, et al.
Published: (2018-07-01) -
Alpha-fetoprotein-producing rectal cancer successfully responded to preoperative chemoradiotherapy: case report
by: Yuki Nakamura, et al.
Published: (2018-09-01) -
Delta-radiomics signature predicts treatment outcomes after preoperative chemoradiotherapy and surgery in rectal cancer
by: Seung Hyuck Jeon, et al.
Published: (2019-03-01) -
2-CONSERVATIVE TREATMENT OF RECTAL ADENOCARCINOMA AFTER NEOADJUVANT CHEMORADIOTHERAPY, IS IT ACCEPTABLE?
by: Majeed H Alwan
Published: (2009-06-01) -
PCSK1 Overexpression in Rectal Cancer Correlates with Poor Response to Preoperative Chemoradiotherapy and Prognosis
by: Chou CL, et al.
Published: (2020-04-01)